Allergy Therapeutics PLC has received a notification of major holdings from Abbott Laboratories, an Illinois corporation. The notification states that Abbott Laboratories, through its subsidiaries, holds a total of 5.06% of the voting rights in Allergy Therapeutics. This represents a decrease from the previous notification, where Abbott Laboratories held 35.45% of the voting rights. The notification also includes details of other shareholders, including Yissum Holding Limited, which holds 2.89% of the voting rights. The notification was received on October 19, 2023.
No further information or details are provided in the news release.